How Much Did Pairwise Raise?
Funding & Key Investors

Pairwise, a leader in applying CRISPR gene-editing technology to food and agriculture, has secured significant enterprise-level funding, with its most recent capital infusion being a major strategic investment. The company's total funding to date stands at $155M, with the latest round contributing $40M to its war chest. This latest financing underscores the growing investor confidence in Pairwise's mission to revolutionize crop development and sustainable food production.

What is Pairwise?

Pairwise
Business ServicesResearch & Development

Pairwise is at the forefront of leveraging advanced CRISPR gene-editing technology to transform the food and agriculture sectors. The company's core objective is to enhance crop yields, improve resilience against climate change impacts, increase the convenience of food consumption, and establish sustainable, plant-based alternatives to traditional, resource-intensive supply chains. By focusing on innovation in plant science, Pairwise aims to address critical global challenges in food security and environmental sustainability.

How much funding has Pairwise raised?

Pairwise has raised a total of $155M across 3 funding rounds:

2018

Series A

$25M

2021

Series B

$90M

2024

Series C

$40M

Series A (2018): $25M with participation from Deerfield and Monsanto Growth Ventures

Series B (2021): $90M led by Deerfield, Leaps by Bayer, Pontifax AgTech Management, and Temasek

Series C (2024): $40M supported by Corteva Agriscience, Aliment Capital, and Deerfield

Key Investors in Pairwise

Corteva Agriscience

Corteva Agriscience is a major player in the agricultural sector, likely providing strategic alignment and market access for Pairwise's innovations.

Aliment Capital

Aliment Capital is a growth capital investor focused on food and agriculture technology, supporting businesses that enhance agricultural productivity and sustainability.

Deerfield

Deerfield Management is an investment firm focused on advancing healthcare, but their participation suggests a broader interest in life sciences and potentially the intersection of health and agriculture.

What's next for Pairwise?

With this substantial enterprise-level backing, Pairwise is poised to accelerate its research and development initiatives and scale its operations. The strategic investment signals a strong market validation for its gene-editing approach in agriculture. Future growth is expected to focus on bringing its innovative crop products to market, further solidifying its position as a key player in the ag-tech landscape and potentially expanding its portfolio of sustainable food solutions. The company's trajectory suggests a continued emphasis on scientific advancement and market penetration.

See full Pairwise company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSecurity Information and Event Management (SIEM)
Business ServicesProject Management
Business ServicesSoftware Testing
Business ServicesChambers of Commerce

Frequently Asked Questions Regarding Pairwise Financial Insights

What are the most recent funding rounds that Pairwise has completed, and what were the funding rounds?
Pairwise has recently completed 3 funding rounds: Series C on Sep 17, 2024, Series B on Feb 3, 2021, Series A on Mar 20, 2018.
What is the total amount of funding Pairwise has raised to date?
Pairwise has raised a total of $155M in funding to date.
How many funding rounds has Pairwise completed?
Pairwise has completed 3 funding rounds.
How much funding did Pairwise raise in its most recent funding round?
Pairwise raised $40M in its most recent funding round.
Who are the lead investors in Pairwise's latest funding round?
The lead investor in Pairwise's latest funding round was Corteva Agriscience. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Pairwise's history?
The largest funding round in Pairwise's history was $90M.
See more information about Pairwise